Neta Krieger
Writer, Father, and Project Manager in 90036
<p class="p__2">2016 Koppel JDS. This is an open-access article distributed under the regards to the Creative Commons Attribution License, which allows unlimited usage, circulation, and recreation in any medium, supplied the original author and source are credited. The moral and medical models, the dominant paradigms of drug dependency, disagree on the question of duty. The medical design views it as the behavior of a' pirated' brain. In the middle of efforts to decarcerate American prisons, the relative merits of these two models are being weighed. Which raises the question of whether policy- makers must be resigned to picking one side of the ethical/ medical dichotomy. In this commentary, the moral and medical models will be critically evaluated, and an alternative 3rd method, a multi-level design, suggested. The important distinction between them is where they put blame for an addicts' habits: the moral model views drug dependency as the option of a totally free and autonomous person; the medical design views it as the item of a' hijacked' brain. For the last a number of years, United States 'drug crime policy has been grounded in the ethical model of dependency: drug-involved offenders are assumed to exercise choice in devoting a criminal offense, are blameworthy, and punishment is warranted either for retributive or consequential purposes. According to this view, habits of a drug abuser is not freely selected but is the outcome of biological procedures. So to blame an addict for his/her conduct-or to impose punishment without attending to the origin of the problem-would be misguided. In the middle of the chorus of calls to decrease imprisonment levels, drug crime policies have when again come to the fore. As reformers think about ways to reduce incarceration levels, the relative merits of the' ethical' and' medical' models.</p>
<p class="p__3">will be under dispute; and the irresolvable differences in between the 2 will be plain - who seeks addiction treatment. Which raises a concern: Must policymakers be resigned to select between the two? Or are there other evidence-based alternatives readily available? In this paper the salient features of the ethical and medical designs of drug dependency, with a focus on empirical proof of their limitations were highlighted.</p>